dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021 at 4:07 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 30-Mar-2021 at 2:39 PM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. In March 2021, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial with batch number 014M20A was initially stored in the fridge on 24-Feb-2021, moved to clinic on 02-Mar-2021 and proposed beyond use date was 26-Mar-2021.  The vial with batch number 019B21A was initially stored in the fridge on 23-Mar-2021, moved to clinic on 30-Mar-2021 and proposed beyond use date was 22-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit.  On 27-Feb-2021, from 09:00 A.M to 05:00 P.M, the temperature recorded were 33, 34 and 35 degrees of Fahrenheit, that has been reached by the vial.  On 28-Feb-2021, at 09:00 A.M to 01:00 P.M, the temperature recorded were 27 and 26 degrees of Fahrenheit, that has been reached by the vial.  On 02-Mar-2021, from 09:00 A.M to 03:00 P.M, the temperature recorded were 27, 29, 32, 33, 35 and 36 degrees of Fahrenheit, that has been reached by the vial.  On 27-Mar-2021, at 09:00 A.M and at 10:00 A.M. the temperature recorded was 35 degree Fahrenheit that has been reached by the vial.  On 28-Mar-2021 and 29-Mar-2021, at 10:00 A.M, the temperature recorded was 35 degree Fahrenheit that has been reached by the vial.  On 30-Mar-2021, at 09:00 A.M., the temperature recorded was 33 degree Fahrenheit that has been reached by the vial.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  No treatment information was provided.   This case was linked to MOD-2022-566976 (Patient Link).